Given that the properties of metal nanoparticles (NPs) depend on several parameters (namely, morphology, size, surface composition, crystalline structure, etc.), a computational model that brings a better understanding of a structure–property relationship at the nanoscale is a significant plus in order to explain the surface properties of metal NPs and also their catalytic viability, in particular, when envisaging a new stabilizing agent. In this study we combined experimental and theoretical tools to obtain a mapping of the surface of ruthenium NPs stabilized by ethanoic acid as a new capping ligand. For this purpose, the organometallic approach was applied as the synthesis method. The morphology and crystalline structure of the obtained particles was characterized by state-of-the art techniques (TEM, HRTEM, WAXS) and their surface composition was determined by various techniques (solution and solid-state NMR, IR, chemical titration, DFT calculations). DFT calculations of the vibrational features of model NPs and of the chemical shifts of model clusters allowed us to secure the spectroscopic experimental assignations. Spectroscopic data as well as DFT mechanistic studies showed that ethanoic acid lies on the metal surface as ethanoate, together with hydrogen atoms. The optimal surface composition determined by DFT calculations appeared to be ca. [0.4–0.6] H/Rusurf and 0.4 ethanoate/RuSurf, which was corroborated by experimental results. Moreover, for such a composition, a hydrogen adsorption Gibbs free energy in the range −2.0 to −3.0 kcal mol−1 was calculated, which makes these ruthenium NPs a promising nanocatalyst for the hydrogen evolution reaction in the electrolysis of water.
15 January 2020 in European Journal of Organic Chemistry
A series of seven novel iridium complexes were synthetized and characterized as potential photosensitizers for photodynamic therapy (PDT) applications. Among them, four complexes were evaluated in vitro for their anti-proliferative activity with and without irradiation on a panel of five cancer cell lines, namely PC-3 (prostate cancer), T24 (bladder cancer), MCF7 (breast cancer), A549 (lung cancer) and HeLa (cervix cancer), and two non-cancerous cell models (NIH-3T3 fibroblasts and MC3T3 osteoblasts). After irradiation at 458 nm, all tested complexes showed a strong selectivity against cancer cells, with a selectivity index (SI) ranging from 8 to 34 compared with non-cancerous cells. The cytotoxic effect of all these complexes was found to be independent of the anti-apoptotic protein Bcl-xL. The compound exhibiting the best selectivity, complex 4a, was selected for further investigations. Complex 4a was mainly localized in the mitochondria. We found that the loss of cell viability and the decrease in ATP and GSH content induced by complex 4a were independent of both Bcl-xL and caspase activation, leading to a non-apoptotic cell death. By counteracting the intrinsic or acquired resistance to apoptosis associated with cancer, complex 4a could be an interesting therapeutic alternative to be studied in preclinical models.
The currently spreading resistance of the malaria parasite Plasmodium falciparum to artemisinin‐based combination therapies makes an urgent need for new efficient drugs. Aiming to kill artemisinin‐resistant Plasmodium, a series of novel hybrid drugs named Atokels were synthesized and characterized. Atokels are based on an 8‐amino‐ or 8‐hydroxyquinoline entity covalently bound to a 1,4‐naphthoquinone through a polyamine linker. These drugs have been designed to target the parasite mitochondrion by their naphthoquinone moiety reminiscent of the antimalarial drug atovaquone, and to trigger a damaging oxidative stress due to their ability to chelate metal ions in order to generate redox active complexes in situ. The most effective Atokel drug shown a promising antimalarial activity (IC50=622 nm on an artemisinin‐resistant P. falciparum strain) and no cytotoxicity at 50 μm indicating a specific antiplasmodial mode of action.
Hydrazone compounds represent an important area of research that includes, among others, synthetic approaches and biological studies. A series of 17 hydrazones have been synthesized by mechanochemical means. The fragments chosen were phenolic and furanyl aldehydes coupled with 12 heterocyclic hydrazines or hydrazinamides. All compounds can be obtained quantitatively when operating on a planetary ball mill and a maximum reaction time of 180 min (6 cycles of 30 min each). Complete spectroscopic analyses of hydrazones revealed eight compounds (3–5, 8–11, 16) present in one geometric form, six compounds (1, 2, 13–15) present in two isomeric forms, and three compounds (6, 7, 12) where one rotation is restricted giving rise to two different forms. The single crystal X-ray structure of one of the hydrazones bearing the isoniazid fragment (8) indicates a crystal lattice consisting of two symmetry-independent molecules with different geometries. All compounds obtained were tested for anti-infectious and antibacterial activities. Four compounds (1, 3, 5 and 8) showed good activity against Mycobacterium tuberculosis, and one (7) was very potent against Staphylococcus aureus. Most interesting, this series of compounds displayed very promising antileishmanial activity. Among all, compound 9 exhibited an IC50 value of 0.3 µM on the Leishmania donovani intramacrophage amastigote in vitro model and a good selectivity index, better than miltefosine, making it worth evaluating in vivo.
24 January 2024 in European Journal of Inorganic Chemistry